# Trade Mark Journal No.2026/030 24 July 2026

## WO0000001926764 (1,5,40,42)

Office of origin: United States of America

Date of International Registration:22 April 2026
Date of designation in the UK: 22 April 2026

The mark consists of the word OMNIULTRA with a chicken comb over the letter "O".

International priority date claimed: 4 November 2025 (United States of America) (99477947)

Class 1
  Synthesized peptides for scientific and research use; reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; proteins and synthesized peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use; biological tissue, namely, animal tissue for use in scientific and medical research; cells for scientific and research use; stem cells for scientific and research use; antibodies for use in further scientific and medical research.
Class 5
  Synthesized peptides for medical use; reagents for biological and chemical purposes and for medical use; chemical reagents used for the detection, measurement and identification of genetic materials or compounds for medical use; biological tissue, namely, animal tissue for medical purposes; cells for scientific and research use; antibodies for use medical use; radiopharmaceutical compositions for diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the diagnosis or treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease; synthesized peptides used in drug discovery of various pharmaceuticals for the treatment of various to different diseases and medical conditions; chemical preparations used in drug discovery for the treatment of various diseases and medical conditions and for pharmaceutical purposes; pharmaceutical preparations for the treatment of various diseases and medical conditions for suppressing tumors; diagnostic preparations for medical purposes; pharmaceutical preparations using synthesized peptides used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes; synthesized proteins and chemical preparations used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes.
Class 40
  Manufacture of synthetic peptides and antibodies to the order and specification of others; peptide and antibody synthesis for others, namely, manufacture of synthetic peptides and antibodies to the order and specification of others.
Class 42
  Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of peptides and antibodies, and the provision of information or advice thereto; testing, examination, namely, inspection and research services in the field of the analysis and synthesis of proteins, and the provision of information or advice thereto; quality control of peptides and antibodies used in drug development; advice on quality control of peptides and antibodies used in drug development; scientific research and development; scientific research and development in the field of immunization and antibody screening.

Crystal Bioscience, Inc.

Representative: Francis P. Cislak Barnes & Thornburg LLP, 11 South Meridian Street, Indianapolis IN 46204-3535, UNITED STATES OF AMERICA